Ortho Clinical Diagnostics Holdings plc (OCDX) Social Stream



Ortho Clinical Diagnostics Holdings plc (OCDX): $17.63

0.08 (+0.46%)

POWR Rating

Component Grades

Momentum

D

Stability

B

Sentiment

Quality

B

Add OCDX to Watchlist
Sign Up

Industry: Medical - Services

Industry

NR

Ranked

#7 of 87

in industry

ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC (OCDX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering OCDX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 8 $32 $23 $27.25 $17.73 53.69%
2021-12-23 7 $30 $23 $26.571 $17.73 49.86%
2021-12-27 7 $27 $23 $25.811 $17.73 45.58%
2022-02-17 7 $27 $16.9 $23.511 $17.73 32.61%
2022-05-05 5 $27 $18.19 $23.811 $17.73 34.3%

The Trend in the Analyst Price Target


OCDX's average price target has moved up $0.3 over the prior 77 days.

OCDX reports an average of 38.76% for its upside potential over the past 42 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-16 12 28 20.0 25.000 20.76 20.42%
2021-09-19 12 30 23.0 26.700 17.75 50.42%
2021-11-04 8 32 23.0 27.250 19.49 39.82%
2022-02-17 7 27 16.9 23.511 16.17 45.4%
2022-02-17 5 27 16.9 23.511 16.17 45.4%

OCDX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.2 2 0 3 0 0 5

The Trend in the Broker Recommendations


Over the past 43 weeks, OCDX's average broker recommendation rating worsened by 0.28.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC fares relative to all US stocks, note that its average analyst price target is higher than 231.87% of that group.
  • OCDX has a greater upside potential (average analyst target price relative to current price) than 105.74% of Pharmaceutical Products stocks.
  • In terms of how ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -94.49% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC's number of analysts covering the stock is greater than 441.09% of them.

Stocks similar to ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NEOG, MYGN, and LNTH.

What is the outlook for OCDX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!